Osteomalacia

• EMA approval · 2026-06-10
  EMA Authorised: Crysvita (burosumab) — Kyowa Kirin Holdings B.V.

  EU authorization for Crysvita (burosumab) for familial hypophosphatemia, X-linked dominant hypophosphatemic rickets, and osteomalacia, grant…

• EMA approval · 2026-04-08
  EMA Authorised: Crysvita (burosumab) — Kyowa Kirin Holdings B.V.

  The EMA authorised Crysvita (burosumab) for X-linked hypophosphatemia and related familial hypophosphatemia and osteomalacia indications, wi…

• FDA approval · 2013-05-15
  FDA Approved: CALCITRIOL — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for CALCITRIOL (calcitriol) from Sun Pharmaceutical Industries, Inc., updating the product’s reg…

• FDA approval · 2010-08-03
  FDA Approved: VITAMIN D — Original Application (Strides Pharma Science Limited)

  FDA approves Strides Pharma Science Limited's generic vitamin D product ergocalciferol under an Original Application (ANDA 090455).